BEL-0216

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBEL-0216
Drug Alias NamePEG-HGH (Belrose Pharma)BEL-0216
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGrowth hormone ligand
TargetsGrowth hormone
Therapy Area/IndicationsGrowth hormone deficiencyTurner Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBelrose Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBelrose Pharma
Active IndicationsN/A
Inactive IndicationsGrowth hormone deficiencyTurner Syndrome

Other Information

ATC CodeN/A
Related LinksN/A